SI
SGYP

Stephens Inc’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Stephens Inc’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,500
Closed -$127K – 918
2017
Q2 		$127K Buy
28,500
+8,000
+39% +$33K ﹤0.01% 817
2017
Q1 		$96K Buy
20,500
+300
+1% +$1.74K ﹤0.01% 801
2016
Q4 		$123K Buy
20,200
+8,200
+68% +$42.9K 0.01% 741
2016
Q3 		$66K Buy
+12,000
New +$56.2K ﹤0.01% 743
2014
Q4 		– Sell
-14,500
Closed -$40K – 861
2014
Q3 		$40K Sell
14,500
-500
-3% -$1.81K ﹤0.01% 781
2014
Q2 		$61K Buy
+15,000
New +$63.7K ﹤0.01% 803

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stephens Inc's SGYP Position: Q3 2017 in Review

Stephens Inc sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2017, closing a stake of 28,500 shares — an estimated $127K sold.

Stephens Inc first reported a position in SGYP in Q2 2014 and held it in 6 quarters. The position peaked at $127K in Q2 2017. 143 funds tracked by Wall St. Rank hold SGYP as of Q3 2017.

  • Stephens Inc reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2017 after selling out during the quarter.
  • Stephens Inc sold 28,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2017, an estimated $127K.
  • Stephens Inc first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2014 and held it in 6 quarters.
  • Stephens Inc's Synergy Pharmaceuticals, Inc Common Stock position peaked at $127K in Q2 2017.
  • 143 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2017.

Based on Stephens Inc's 13F filing for Q3 2017, filed 8 Nov 2017.